Clinical evaluation lead site

Ended Awarded Last action

Contract number
HHSD2002012504300005
Awardee
Awarding agency
Obligated
$4,861,442

Award facts

Opportunity
  • 2012N14296 Solicitation number
Contract value 100% obligated
$4,879,802.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Nashville, TN 37232, USA
Legislative mandates
  • Other statutory authority
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 8 $0
Supplemental Agreement for work within scope 7 $1,687,387
Supplemental Agreement for work within scope 6 · Clinical evaluation lead site covid response modification $1,607,125
Exercise an Option 5 $393,406
Other Administrative Action 4 $0
Exercise an Option 3 · Clinical evaluation lead site modification to exercise option $398,998
Exercise an Option 2 $390,186
Other Administrative Action 1 $0
Original award $384,340

About this award

This is a federal contract award to The Vanderbilt University, a private research university, by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) for CLINICAL EVALUATION LEAD SITE services. The $4,879,802.00 contract is a Delivery Order under the larger Clinical Immunization Safety Assessment (CISA) contract vehicle. The award does not have a set-aside designation. As the prime contractor, Vanderbilt University will provide critical research and educational services to advance science and serve patient populations, including areas such as clinical trials, medical research, education/training services, program evaluations, and data analysis. This award supports the CDC's work related to the Coronavirus COVID-19 national interest action.

Quick answers

Who was awarded contract HHSD2002012504300005?

HHSD2002012504300005 was awarded to The Vanderbilt University by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 29, 2017.

How much is contract HHSD2002012504300005 worth?

The government has obligated $4,861,442 on HHSD2002012504300005. Its current value, with exercised options, is $4,879,802.

Is contract HHSD2002012504300005 an order under another contract?

Yes. HHSD2002012504300005 is a delivery order under HHSD200201250430I, an indefinite delivery contract, on Clinical Immunization Safety Assessment (CISA).

Was contract HHSD2002012504300005 competed?

The extent of competition for HHSD2002012504300005 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award